What is Sensogram Technologies?
Sensogram Technologies operates as an international research and development powerhouse dedicated to the design, production, and marketing of intuitive wireless mobile devices. The company distinguishes itself through its proprietary biosensor technology, which facilitates real-time, continuous, and remote monitoring of critical human vital signs and physiological parameters. Central to its market value is the development of unique, non-invasive sensors capable of tracking blood pressure and respiration rates, a breakthrough that addresses a critical gap in telehealth and chronic disease management. By prioritizing user-friendly interfaces and high-fidelity data collection, Sensogram Technologies is effectively bridging the divide between clinical-grade diagnostics and consumer-accessible mobile health solutions.
How much funding has Sensogram Technologies raised?
Sensogram Technologies has raised a total of $76K across 1 funding round:
Debt
$76K
Debt (2021): $76K with participation from PPP
Key Investors in Sensogram Technologies
PPP
Public-Private Partnership
What's next for Sensogram Technologies?
With the recent infusion of capital, Sensogram Technologies is poised to transition into a more aggressive scaling phase. The strategic focus will likely center on expanding its manufacturing capabilities and securing broader regulatory approvals to facilitate global market penetration. As the demand for remote health monitoring continues to surge, the company's ability to scale its non-invasive monitoring platform will be a key determinant of its long-term success. Investors and industry analysts will be closely monitoring the firm's progress in integrating its biosensors into broader healthcare ecosystems, as it seeks to establish its technology as the standard for continuous, mobile physiological tracking.
See full Sensogram Technologies company page
